EMBO Workshop: Chemical Biology 2020
02 September 2020 - 05 September 2020
The conference sets the stage for the dissemination and exchange of new developments in diverse, hot fields within chemical biology, being the platform for inspiration, collaboration and networking for researchers in academia and industry. It is the largest, and longest standing conference in the field, giving over 300 participants multiple opportunities to actively participate. We aim to provide the possibility for every chemical biologist to meet and discuss with peers, from tool development to biological applications, from computational drug design to synthetic chemistry. Most importantly, participants come to see where the field stands in its full breadth.
Virtual
https://www.embl.de/training/events/2020/CHB20-01/index.html?utm_source=drugdiscoverytoday&utm_medium=referral&utm_campaign=CHB20-01
Pre-filled Syringes San Francisco
14 September 2020 - 15 September 2020
SMi is proud to announce the inaugural Prefilled Syringes San Francisco event taking place in September 2020.
The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human studies and innovative design and delivery systems within the prefilled syringe industry.
As part of SMi's leading Injectable conference series, we will assess digital health and connected devices, biologics, biosimilars and biocompatibility for drug device combination products, platform and device selection, regulatory insights and explore the West Coast's biotech innovators.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Device Testing Managers, Senior Device Engineers, Heads of Device Development, Heads of Formulation and Drug Process Development, and many more.
Hyatt Centric Fisherman's Wharf, San Francisco
https://www.smi-online.co.uk/pharmaceuticals/northamerica/prefilled-syringes-san-fransico?utm_medium=www.prefilled-sanfrancisco.com&utm_source=P-326&utm_campaign=DDTwl
Healthtech Leaders: Virtual Partnering & Investment
15 September 2020 - 18 September 2020
Healthtech Leaders: Virtual Partnering & Investment is a c-level, online showcase and partnering experience designed to provide a platform for Healthtech companies to engage international investors, strategic partners, payors and providers.
The online experience combines live-streamed and on-demand investor, strategic partner, corporate and reimbursor executive panels, interactive CEO Forums, company showcases and the all-important video-enabled 1:1 partnering across four-full days, 15-18 September 2020.
All of the content sessions are offered at no charge. Passes can be upgraded to include 1:1 partnering.
You can see the full agenda, speakers and partnering opportunities by visiting the website.
Virtual Conference
http://www.lsxleaders.com/healthtech
Oligonucleotide Therapeutics and Delivery Conference
16 September 2020 - 17 September 2020
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered “non-draggable”. Heavy investments in oligonucleotide therapeutic discovery have created an emerging market need for drug delivery technologies.
SMi’s inaugural Oligonucleotide Therapeutics and Delivery conference is here to keep you updated. By bringing together leading representatives of pharmaceutical, biotechnology and academic institutions, the 2-day conference will provide first-hand information on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY. From optimizing particle size to choosing the right nanocarrier systems, the conference will address delivery to non-hepatocyte cells such as cancerous tissues and overview the most successful platforms. Discussions will be centered around improving targeted therapy uniting the field’s biggest players to share their opinions.
Holiday Inn Kensington Forum, London
http://www.oligonucleotide.co.uk/DDTwl